John Gribben Selected Research

John Gribben Research Topics

Disease

13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023 - 11/2005
11	Neoplasms (Cancer) 01/2023 - 09/2005
6	Leukemia 12/2023 - 04/2006
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 08/2010
6	Lymphoma (Lymphomas) 01/2021 - 02/2010
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 09/2012
4	Crohn Disease (Crohn's Disease) 02/2024 - 12/2015
4	Disease Progression 12/2023 - 12/2007
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2016 - 02/2010
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 01/2021
2	Infections 12/2023 - 02/2009
2	Multiple Myeloma 01/2022 - 02/2010
2	Residual Neoplasm 01/2020 - 04/2013
1	Ulcer 02/2024
1	Sepsis (Septicemia) 02/2024
1	Genomic Instability 01/2021
1	Inflammation (Inflammations) 05/2019
1	Chronic Disease (Chronic Diseases) 11/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Neutropenia 08/2016
1	Thrombocytopenia (Thrombopenia) 08/2016
1	Hypoxia (Hypoxemia) 11/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2013
1	Hodgkin Disease (Hodgkin's Disease) 08/2010
1	Respiratory Syncytial Virus Infections 09/2009

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 01/2021 - 02/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 11/2009
3	Phosphotransferases (Kinase)IBA 12/2023 - 03/2013
3	Bendamustine Hydrochloride FDA Link 08/2016 - 02/2010
3	fludarabineIBA 11/2009 - 11/2005
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 04/2014
2	Neoplasm Antigens (Tumor Antigens)IBA 04/2013 - 04/2006
1	ibrutinibIBA 12/2023
1	venetoclaxIBA 12/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	axicabtagene ciloleucelIBA 01/2023
1	ublituximabIBA 12/2021
1	umbralisibIBA 12/2021
1	acalabrutinibIBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	vistusertibIBA 11/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	histone H3 trimethyl Lys4IBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	sphingosine kinaseIBA 01/2020
1	teleocalcinIBA 01/2020
1	CeramidesIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 05/2019
1	AntigensIBA 05/2019
1	CytokinesIBA 01/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2017
1	Vincristine (Oncovin)FDA LinkGeneric 01/2017
1	Genetic Markers (Genetic Marker)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Prednisone (Sone)FDA LinkGeneric 01/2017
1	obinutuzumabIBA 08/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2015
1	purineIBA 12/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2014
1	Oxygen (Dioxygen)IBA 11/2013
1	idelalisibIBA 03/2013
1	Alkylating AgentsIBA 02/2010
1	oblimersen (G3139)IBA 11/2009
1	Monoclonal AntibodiesIBA 09/2009
1	Ribavirin (Virazole)FDA LinkGeneric 09/2009
1	Palivizumab FDA Link 09/2009
1	Alemtuzumab (Campath)FDA Link 02/2009
1	Bortezomib (Velcade)FDA Link 09/2006
1	VaccinesIBA 04/2006
1	alvocidib (flavopiridol)IBA 11/2005

Therapy/Procedure

13	Therapeutics 12/2023 - 04/2006
8	Stem Cell Transplantation 02/2024 - 04/2013
4	Drug Therapy (Chemotherapy) 01/2023 - 08/2010
4	Transplantation 01/2022 - 09/2012
4	Hematopoietic Stem Cell Transplantation 06/2016 - 12/2014
2	Biological Therapy 02/2024 - 05/2019
2	Cell Transplantation 01/2023 - 12/2016
2	Immunotherapy 04/2013 - 09/2005
1	Homologous Transplantation 06/2016
1	Aftercare (After-Treatment) 08/2010